XFEL structure of carbonic anhydrase II: a comparative study of XFEL, NMR, X-ray and neutron structures. [PDF]
Hull JA +15 more
europepmc +1 more source
Design, Synthesis and Molecular Docking Study of Novel 3-Phenyl-β-Alanine-Based Oxadiazole Analogues as Potent Carbonic Anhydrase II Inhibitors. [PDF]
Rafiq K +5 more
europepmc +1 more source
Structure and mechanism of copper-carbonic anhydrase II: a nitrite reductase. [PDF]
Andring JT, Kim CU, McKenna R.
europepmc +1 more source
Design, synthesis, and in vitro and in silico studies of morpholine derived thiazoles as bovine carbonic anhydrase-II inhibitors. [PDF]
Tasleem M +11 more
europepmc +1 more source
Evaluation of Human Carbonic Anhydrase II (CA-II) Concentration Using ELISA: Insights into Optical Density's Role in Biomarker Quantification for Cryptorchidism Research. [PDF]
Nurhadi P +4 more
europepmc +1 more source
Pregnenolone derivatives for the treatment of Alzheimer's disease: synthesis, and in vitro inhibition of amyloid β1-42 peptide aggregation, acetylcholinesterase and carbonic anhydrase-II. [PDF]
Tahir A +4 more
europepmc +1 more source
Structural details of the enzymatic catalysis of carbonic anhydrase II via a mutation of valine to isoleucine. [PDF]
Matulis D.
europepmc +1 more source
Identification and Validation of Carbonic Anhydrase II as the First Target of the Anti-Inflammatory Drug Actarit. [PDF]
Ghislat G, Rahman T, Ballester PJ.
europepmc +1 more source
Molecular Docking Analysis of Selected Urtica dioica Constituents As Human Carbonic Anhydrase II (hCA-II), Human 11 Beta-Hydroxysteroid Dehydrogenases Type 1 (h11beta-HSD1), and Human Dual Specificity Phosphatase (hCDC25B) Inhibitory Agents. [PDF]
Arulselvan AJ +2 more
europepmc +1 more source

